Shockwave Medical Inc. (NASDAQ:SWAV)

A significant financial transformation is observed between 2019 and 2023, characterized by a transition from consistent operating losses to substantial profitability. The trajectory indicates an initial period of capital intensity and losses, followed by a rapid acceleration in earnings across all measured metrics starting in 2021.

EBITDA Growth and Trajectory

Earnings before interest, tax, depreciation and amortization exhibited a sharp reversal after 2020. Following a trough of negative 62.54 million US dollars in 2020, EBITDA improved to near break-even levels in 2021 at negative 4.16 million US dollars. This was followed by a substantial increase to 127.57 million US dollars in 2022 and a further rise to 191.54 million US dollars by the end of 2023, representing a strong upward trend in core operational profitability.

Operational Inflection Point

The transition between 2021 and 2022 serves as the primary inflection point for the organization. The shift from a marginal loss to a positive EBITDA of 127.57 million US dollars suggests a successful scaling of operations or a significant increase in revenue efficiency that effectively outpaced the growth of operating expenses.

Divergence Between EBITDA and Net Income

A notable divergence is observed between EBITDA and net income in the final two years of the period. While net income peaked in 2022 at 215.99 million US dollars before declining to 147.27 million US dollars in 2023, EBITDA continued to grow, reaching its peak of 191.54 million US dollars in 2023. This pattern indicates that while the bottom line was affected by non-operating factors—such as taxes or interest—the fundamental operational cash flow generation remained on a growth trajectory.

Analysis of Earnings Layers

The consistent gap between EBITDA, EBIT, and EBT highlights the ongoing impact of depreciation, amortization, and interest expenses. The steady increase in EBIT from negative 7.73 million US dollars in 2021 to 181.18 million US dollars in 2023 mirrors the EBITDA trend, confirming that the growth is driven by operational performance rather than one-time accounting adjustments.

A significant expansion in enterprise value and a transition toward operational profitability are observed between 2019 and 2023. The trajectory indicates a shift from a high-growth, loss-making phase to a period of positive earnings and increased market valuation.

Enterprise Value Trend

The enterprise value experienced rapid growth over the five-year period, rising from 739,674 thousand US$ in 2019 to 9,460,368 thousand US$ by the end of 2023. The most substantial increase occurred between 2019 and 2020, where the value grew more than fivefold, followed by a steady upward trajectory in subsequent years.

EBITDA Performance

Operational profitability evolved from negative to positive. Initial losses of 48,766 thousand US$ in 2019 deepened slightly in 2020 to 62,544 thousand US$, before narrowing significantly to 4,160 thousand US$ in 2021. A definitive turnaround was achieved in 2022 with a positive EBITDA of 127,570 thousand US$, which further increased to 191,544 thousand US$ in 2023.

EV/EBITDA Ratio Analysis

The EV/EBITDA ratio was not applicable from 2019 to 2021 due to negative EBITDA. Upon reaching profitability in 2022, the ratio was recorded at 52.02. By 2023, the ratio decreased slightly to 49.39. This contraction suggests that while the enterprise value continued to climb, the growth in EBITDA occurred at a rate that moderately offset the increase in valuation, leading to a marginal compression of the multiple.